Corona Remedies

{
  "main_header": {
    "sid": 10039887,
    "name": "Corona Remedies",
    "stock_name": "Corona Remedies",
    "full_name": "Corona Remedies Ltd",
    "name_url": "stocks-analysis/corona-remedies",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,746.60",
    "chg": -5.95,
    "chgp": "-0.34%",
    "dir": -1,
    "prev_price": "1,752.55",
    "mcapval": "10,802.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544644,
    "symbol": "CORONA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE02ZQ01018",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "11.44 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/corona-remedies-10039887-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039887",
    "stock_news_url": "https://www.marketsmojo.com/news/corona-remedies-10039887"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Audited Financial Results On Standalone And Consolidated Basis For The Fourth Quarter And Year Ended On March 31 2026",
      "datetime": "30-Apr-2026",
      "details": "Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 inter alia to consider and approve a) Audited Financial Results on Standalone and Consolidated basis for the Fourth Quarter and Year ended on March 31 2026; b) recommendation of final dividend if any on the equity shares of the Company for the financial year ended March 31 2026 for approval of the shareholders at the ensuing Annual General Meeting.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "30-Apr-2026",
      "details": "Intimation of Schedule of Analyst / Investor Call",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the fourth quarter ended March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News